1 December 1997 | Volume 127 Issue 11 | Pages 1023-1028
Purpose: To determine how many cases of breast cancer might be found if women not known to have the disease were thoroughly examined (the disease "reservoir").
Data Sources: MEDLINE search from 1966 to the present.
Study Selection: Hospital-based and forensic autopsy series examining women not known to have had breast cancer during life.
Data Extraction: Observed prevalence of occult invasive breast cancer or ductal carcinoma in situ (DCIS) in which the number of women who were given a diagnosis was the numerator and the number of women examined was the denominator. For each autopsy series, we attempted to ascertain the level of scrutiny (sampling method, number of slides examined) given to the pathologic specimens.
Data Synthesis: Among seven autopsy series of women not known to have had breast cancer during life, the median prevalence of invasive breast cancer was 1.3% (range, 0% to 1.8%) and the median prevalence of DCIS was 8.9% (range, 0% to 14.7%). Prevalences were higher among women likely to have been screened (that is, women 40 to 70 years of age). The mean number of slides examined per breast ranged from 9 to 275; series that reported higher levels of scrutiny tended to discover more cases of cancer.
Conclusions: A substantial reservoir of DCIS is undetected during life. How hard pathologists look for the disease and, perhaps, their threshold for making the diagnosis are potentially important factors in determining how many cases of DCIS are diagnosed. The latter has important implications for what it means to have the disease.
Author and Article Information
From the Department of Veterans Affairs Medical Center, White River Junction, Vermont; Dartmouth Medical School, Hanover, New Hampshire; and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
REVIEW
Using Autopsy Series To Estimate the Disease "Reservoir" for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find?
![]()
Acknowledgments: The authors thank Rick Haver, Chief of the Library Service, Department of Veterans Affairs Medical Center, White River Junction, Vermont, for performing the literature searches; Roger Goldstein for assistance in obtaining the articles; and Robert Pritchard, MD, Lisa Schwartz, MD, Wendy Wells, MD, and Steve Woloshin, MD, for thoughtful comments on the manuscript.
Grant Support: Dr. Welch was supported by a Veterans Affairs Career Development Award in health services research and development.
Requests for Reprints: H. Gilbert Welch, MD, MPH, VA Outcomes Group (111B), Department of Veterans Affairs Medical Center, White River Junction, VT 05009.
Current Author Addresses: Dr. Welch: VA Outcomes Group (111B), Department of Veterans Affairs Medical Center, White River Junction, VT 05009.
Related articles in Annals:
This article has been cited by other articles:
![]() |
K. B. Horwitz Commentary: The Year in Basic Science: Update of Estrogen Plus Progestin Therapy for Menopausal Hormone Replacement Implicating Stem Cells in the Increased Breast Cancer Risk Mol. Endocrinol., December 1, 2008; 22(12): 2743 - 2750. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kaplan and F. Porzsolt The Natural History of Breast Cancer Arch Intern Med, November 24, 2008; 168(21): 2302 - 2303. [Full Text] [PDF] |
||||
![]() |
P. Loubeyre, P. Petignat, and F. M. Hall Is the Field of Breast Imaging Moving toward Broader Use of MR Imaging? Radiology, November 1, 2008; 249(2): 721 - 722. [Full Text] [PDF] |
||||
![]() |
K. B. Horwitz and C. A. Sartorius Progestins in Hormone Replacement Therapies Reactivate Cancer Stem Cells in Women with Preexisting Breast Cancers: A Hypothesis J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3295 - 3298. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Willimsky, M. Czeh, C. Loddenkemper, J. Gellermann, K. Schmidt, P. Wust, H. Stein, and T. Blankenstein Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness J. Exp. Med., July 7, 2008; 205(7): 1687 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Welch, S. Woloshin, and L. M. Schwartz The Sea of Uncertainty Surrounding Ductal Carcinoma In Situ--The Price of Screening Mammography J Natl Cancer Inst, February 20, 2008; 100(4): 228 - 229. [Full Text] [PDF] |
||||
![]() |
M. A. de Roos, B. van der Vegt, J. de Vries, J. Wesseling, and G. H. de Bock Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast Ann. Surg. Oncol., July 1, 2007; 14(7): 2097 - 2104. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Fryback, N. K. Stout, M. A. Rosenberg, A. Trentham-Dietz, V. Kuruchittham, and P. L. Remington Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 37 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Jorgensen and P. C Gotzsche Content of invitations for publicly funded screening mammography. BMJ, March 4, 2006; 332(7540): 538 - 541. [Full Text] [PDF] |
||||
![]() |
A. M. Geiger, O. Yu, L. J. Herrinton, W. E. Barlow, E. L. Harris, S. Rolnick, M. B. Barton, J. G. Elmore, and S. W. Fletcher A Population-Based Study of Bilateral Prophylactic Mastectomy Efficacy in Women at Elevated Risk for Breast Cancer in Community Practices Arch Intern Med, March 14, 2005; 165(5): 516 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. BERMAN, J. ZHANG, Y.G. CRAWFORD, M.L. GAUTHIER, C.A. FORDYCE, K.M. McDERMOTT, M. SIGAROUDINIA, K. KOZAKIEWICZ, and T.D. TLSTY Genetic and Epigenetic Changes in Mammary Epithelial Cells Identify a Subpopulation of Cells Involved in Early Carcinogenesis Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 317 - 327. [Abstract] [PDF] |
||||
![]() |
H. Joensuu, T. Lehtimaki, K. Holli, L. Elomaa, T. Turpeenniemi-Hujanen, V. Kataja, A. Anttila, M. Lundin, J. Isola, and J. Lundin Risk for Distant Recurrence of Breast Cancer Detected by Mammography Screening or Other Methods JAMA, September 1, 2004; 292(9): 1064 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
I S Cook and C E Fuller Does histopathological examination of breast reduction specimens affect patient management and clinical follow up? J. Clin. Pathol., March 1, 2004; 57(3): 286 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kaplan, T. G. Ganiats, and D. L. Frosch Diagnostic and Treatment Decisions in US Healthcare J Health Psychol, January 1, 2004; 9(1): 29 - 40. [Abstract] [PDF] |
||||
![]() |
S. W. Fletcher and J. G. Elmore Mammographic Screening for Breast Cancer N. Engl. J. Med., April 24, 2003; 348(17): 1672 - 1680. [Full Text] [PDF] |
||||
![]() |
C. R. Holst, G. J. Nuovo, M. Esteller, K. Chew, S. B. Baylin, J. G. Herman, and T. D. Tlsty Methylation of p16INK4a Promoters Occurs in Vivo in Histologically Normal Human Mammary Epithelia Cancer Res., April 1, 2003; 63(7): 1596 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Ernster, R. Ballard-Barbash, W. E. Barlow, Y. Zheng, D. L. Weaver, G. Cutter, B. C. Yankaskas, R. Rosenberg, P. A. Carney, K. Kerlikowske, et al. Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography J Natl Cancer Inst, October 16, 2002; 94(20): 1546 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Schwartz and S. Woloshin News Media Coverage of Screening Mammography for Women in Their 40s and Tamoxifen for Primary Prevention of Breast Cancer JAMA, June 19, 2002; 287(23): 3136 - 3142. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Welch Informed Choice in Cancer Screening JAMA, June 6, 2001; 285(21): 2776 - 2778. [Full Text] [PDF] |
||||
![]() |
L. M Schwartz, S. Woloshin, H. C Sox, B. Fischhoff, and H G. Welch US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey BMJ, June 17, 2000; 320(7250): 1635 - 1640. [Abstract] [Full Text] |
||||
![]() |
S. Y. Moody-Ayers, C. K. Wells, and A. R. Feinstein "Benign" Tumors and "Early Detection" in Mammography-Screened Patients of a Natural Cohort With Breast Cancer Arch Intern Med, April 24, 2000; 160(8): 1109 - 1115. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Ernster, J. Barclay, K. Kerlikowske, H. Wilkie, and R. Ballard-Barbash Mortality Among Women With Ductal Carcinoma In Situ of the Breast in the Population-Based Surveillance, Epidemiology and End Results Program Arch Intern Med, April 10, 2000; 160(7): 953 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Barton, R. Harris, and S. W. Fletcher Does This Patient Have Breast Cancer?: The Screening Clinical Breast Examination: Should It Be Done? How? JAMA, October 6, 1999; 282(13): 1270 - 1280. [Abstract] [Full Text] [PDF] |
||||